Fatty acid synthase: An early molecular marker of progression of prostatic adenocarcinoma to androgen independence

Journal of Urology

Volumn 165, Issue 3, 2001, Pages 1027-1032

  Myers, Russell B ^a   Oelschlager, Denise K ^a   Weiss, Heidi L ^a   Frost, Andra R ^a   Grizzle, William E ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Adenocarcinoma; Androgens; Disease progression; Prostate; Prostatic neoplasms

Indexed keywords

ANDROGEN; FATTY ACID SYNTHASE; PROTEIN P21; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; DISEASE MARKER; GENE EXPRESSION; HORMONE DEPENDENCE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; TUMOR GROWTH; TUMOR VOLUME;

EID: 0035131412     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)66596-2     Document Type: Article

References (28)

1. Cancer Statistics, 1999
2. The animal fatty acid synthase: One gene, one polypeptide, seven enzymes
3. The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node negative breast cancer
4. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage 1 breast carcinoma patients
5. Expression of fatty acid synthase in colorectal cancer
6. Fatty acid synthase expression is increased in neoplastic lesions of the oral tongue
7. Expression of oncogenic antigen 519 (OA-519) in prostate cancer is a potential prognostic indicator
8. Immunohistochemical detection of fatty acid synthase (OA-519) as a predictor of progression of prostate cancer
9. OA-519 (fatty acid synthase) as an independent predictor of pathologic stage in adenocarcinoma of the prostate
10. Coordinate regulation of lipogenic gene expression by androgens: Evidence for a cascade mechanism involving sterol regulatory element binding proteins
11. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP
12. Progestin increases gene transcription and messenger ribonucleic acid stability of fatty acid synthase in breast cancer cells
13. Effects of progestins and menstral cycle on fatty acid synthase and progesterone receptor in human mammary glands
14. CWR22: Androgen dependent xenograft model derived from a primary human prostatic carcinoma
15. Changes in cyclin dependent kinase inhibitors p21 and p27 during the castration induced regression of the CWR22 model of prostatic adenocarcinoma
16. Prostate cancer cell cycle regulators: Response to androgen withdrawal and development of androgen independence
17. CWR22: The first human prostate xenograft with strongly androgen dependent and relapsed strains both in vivo and in soft agar
18. The effects of estroneprogesterone treatment on cell proliferation kinetics of hormone dependent GR mouse mammary tumors
19. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
20. Biomarker expression and prostatic intraepithelial neoplasia
21. p27Kip-1, A cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest
22. Hormone refractory (D3) prostate cancer: Refining the concept
23. Orchiectomy versus goserelin and flutamide in the treatment of newly diagnosed metastatic prostate cancer. Analysis of the criteria of evaluation used in the European Organization for Research and Treatment of Cancer Genitourinary Group Study 30853
24. Androgen receptor activation in prostate tumor cell lines by insulin like growth factor-I, keratinocyts growth factor and epidermal growth factor
25. Fatty acid synthase expression in endometrial carcinoma: Correlation with cell proliferation and hormone receptors
26. Coordination of membrane phospholipid synthesis with the cell cycle
27. Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines
28. Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer